1. Home
  2. companies
  3. JNJ

JNJ

Plaintiffs to J&J on fraud claims: Prove it
Plaintiffs to J&J on fraud claims: Prove it
Mass Device
JNJ
fraud
devices
pelvic mesh
FDA expands use of Imbruvica to treat rare form of blood cancer
FDA expands use of Imbruvica to treat rare form of blood cancer
Yahoo/Reuters
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Johnson & Johnson: Beyond The Q4 Headlines
Johnson & Johnson: Beyond The Q4 Headlines
Seeking Alpha
JNJ
earnings
J&J employee sniffs out spy camera in unisex bathroom
J&J employee sniffs out spy camera in unisex bathroom
Fierce Pharma
JNJ
Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits
Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits
Yahoo/Reuters
JNJ
pelvic mesh
devices
Ethicon
J&J eyes long-acting boost for Invega franchise with quick FDA look at new formula
J&J eyes long-acting boost for Invega franchise with quick FDA look at new formula
Fierce Pharma Marketing
JNJ
Invega Sustenna
antipsychotics
Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge
Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge
Yahoo/Reuters
JNJ
Boston Scientific
devices
Guidant
M&A
Drugs’ Path to China Slows as Regulatory Delays Add Up, J&J Says
Drugs’ Path to China Slows as Regulatory Delays Add Up, J&J Says
Bloomberg
China
JNJ
Johnson & Johnson beats profit expectations, but sales fall shy
Johnson & Johnson beats profit expectations, but sales fall shy
Marketwatch
JNJ
earnings
Johnson & Johnson Will Make Clinical Data Available to Outside Researchers
Johnson & Johnson Will Make Clinical Data Available to Outside Researchers
NY Times, NY
JNJ
clinical trial data
PaxVax ready to strike M&A deals that prove its sales model, CEO says
PaxVax ready to strike M&A deals that prove its sales model, CEO says
Fierce Vaccines
PaxVax
vaccines
M&A
JNJ
Vivotif
Abandonment rates indicate room in the anti-TNF market
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
anti-TNF
JNJ
Remicade
Humira
AbbVie
Biogen Idec
J&J Ebola vaccine gets 100 mln euros to speed development
J&J Ebola vaccine gets 100 mln euros to speed development
Yahoo/Reuters
JNJ
ebola virus
vaccines
Earnings Preview: Johnson & Johnson Q4 2014
Earnings Preview: Johnson & Johnson Q4 2014
Seeking Alpha
earnings
JNJ
Depomed to pay $1 bln for J&J pain drug franchise
Depomed to pay $1 bln for J&J pain drug franchise
Yahoo/Reuters
Depomed
JNJ
painkillers
M&A
Nucynta
Receptos Shopping For A Partner With Strong Data In Hand
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
J&J says women being illegally solicited to join in mesh lawsuits
J&J says women being illegally solicited to join in mesh lawsuits
Yahoo/Reuters
JNJ
pelvic mesh
Ethicon
devices
Buried Clinical Trial Data: The Dam Is About To Burst
Buried Clinical Trial Data: The Dam Is About To Burst
Forbes
clinical trial data
JNJ
J&J in deal to develop microbiome drug for bowel diseases
J&J in deal to develop microbiome drug for bowel diseases
Yahoo/Reuters
JNJ
microbiome
inflammatory bowel disease
Vedanta Biosciences
J&J strikes Alzheimer's deal with AC Immune worth up to $509 mln
J&J strikes Alzheimer's deal with AC Immune worth up to $509 mln
Yahoo/Reuters
JNJ
Alzheimer's disease
AC Immune
anti-tau vaccines

Click here to subscribe to daily news headlines in your email inbox